Bone Targeting Agents in Patients with Prostate Cancer: General Toxicities and Osteonecrosis of the Jaw.

Introduction: Bone metastases are the most frequent site of secondary localization of prostate cancer (PCa) and are present in about 90% of cases of advanced disease. Consequently, an adequate management of bone involvement is of pivotal importance in the therapeutic approach and skeletal-related ev...

Descripción completa

Detalles Bibliográficos

Publicado en:	Current Oncology Vol. 29; no. 3; pp. 1709 - 1723
Autores principales:	Mollica, Veronica, Nuvola, Giacomo, Tassinari, Elisa, Nigro, Maria Concetta, Marchetti, Andrea, Rosellini, Matteo, Rizzo, Alessandro, Errani, Costantino, Massari, Francesco
Formato:	review tables/charts Journal Article
Publicado:	MDPI Mar2022
Acceso en línea:	Ver este registro en EBSCOhost